General Information of the Compound
Compound ID |
CP0167140
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
CHEBI:681848
Show/Hide
|
||||||||||||||||||
Synonyms |
(+-)-doxapram
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one
1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-(9CI)
Docatone
Docatone (TN)
Dopram
Dopram (TN)
Doxapram
Doxapram (INN)
Doxapram HCL
Doxapram [USP:JAN]
Doxapram hydrochloride
Doxapramum
Doxapramum [INN-Latin]
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C24H30N2O2
|
||||||||||||||||||
Molecular Weight |
378.516
|
||||||||||||||||||
Canonical SMILES |
CCN1CC(CCN2CCOCC2)C(C1=O)(c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C24H30N2O2/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,22H,2,13-19H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
XFDJYSQDBULQSI-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
309-29-5
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound